Sign In
Buy CRMD
$8.23
+0.0600 (+0.734%)
At Close: Jun 03, 2026
New York, New York--(Newsfile Corp. - July 28, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CorMedix Inc. (NASDAQ: CRMD) alleging that
NEW YORK, July 28, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against CorMedix Inc. ("CorMedix" or the "Company") (NASDAQ: CRMD) and certain of its officer
SHAREHOLDER ALERT: Robbins LLP Announces that CorMedix Inc. (CRMD) is Being Sued for Misleading Shareholders
05:27pm, Wednesday, 28'th Jul 2021
SAN DIEGO--(BUSINESS WIRE)---- $CRMD #CRMD--Shareholder rights law firm Robbins LLP announces that a class action has been filed on behalf of all purchasers of CorMedix Inc. (NASDAQ: CRMD) between Jul
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of CorMedix Inc. (CRMD) on Behalf of Investors
01:57pm, Wednesday, 28'th Jul 2021
BENSALEM, Pa.--(BUSINESS WIRE)---- $CRMD #CLASSACTION--Law Offices of Howard G. Smith announces an investigation on behalf of CorMedix Inc. (“CorMedix” or the “Company”) (NASDAQ: CRMD) investo
CorMedix Inc. to Report Second Quarter 2021 Financial Results and Provide a Corporate Update on August 12
08:30am, Wednesday, 28'th Jul 2021
BERKELEY HEIGHTS, N.J., July 28, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention an
CRMD NOTICE: Investors With Substantial Losses Have Opportunity to Lead the CorMedix Inc. Class Action Lawsuit
08:05pm, Tuesday, 27'th Jul 2021
San Diego, California--(Newsfile Corp. - July 27, 2021) - The CorMedix class action lawsuit charges CorMedix Inc. (NASDAQ: CRMD) and certain of its top executives with violations of the Securities Exc
LOS ANGELES--(BUSINESS WIRE)---- $CRMD #CRMD--SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CorMedix Inc.
NEW YORK, July 26, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of CorMedix Inc
New York, New York--(Newsfile Corp. - July 26, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CorMedix Inc. (NASDAQ: CRMD) alleging th
LOS ANGELES--(BUSINESS WIRE)---- $CRMD #CRMD--SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CorMedix Inc.
New York, New York--(Newsfile Corp. - July 26, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of CorMedix Inc. (NASDAQ: CR
CORMEDIX ALERT: Investors With Substantial Losses Have Opportunity to Lead the CorMedix Inc. Class Action Lawsuit - CRMD
09:35am, Monday, 26'th Jul 2021
SAN DIEGO, July 26, 2021 /PRNewswire/ -- The CorMedix class action lawsuit charges CorMedix Inc. (NASDAQ: CRMD) and certain of its top executives with violations of the Securities Exchange Act of 193
NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against CorMedix Inc. (“CorMedix”
CRMD ALERT: Investors With Substantial Losses Have Opportunity to Lead the CorMedix Inc. Class Action Lawsuit
07:15pm, Friday, 23'rd Jul 2021
SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that purchasers of CorMedix Inc. (NASDAQ: CRMD) securities between July 8, 2020 and May 13, 2021, inclusive (“Class Period”)
